HEADER MEMBRANE PROTEIN 26-OCT-23 8URT TITLE MEMBRANE PROTEIN ENZYME WITH A SPECIFIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINEPHOSPHOTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BREWER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932; SOURCE 5 STRAIN: S228C; SOURCE 6 ATCC: 204508; SOURCE 7 GENE: CPT1; SOURCE 8 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACCULOVIRAL; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS LIPID METABOLISM, PHOSPHOLIPID SYNTHESIS, MEMBRANE PROTEIN ENZYME, KEYWDS 2 CHOLINE METABOLISM, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR J.R.ROBERTS,S.MAEDA,M.D.OHI REVDAT 4 27-NOV-24 8URT 1 REMARK REVDAT 3 20-NOV-24 8URT 1 REMARK REVDAT 2 06-NOV-24 8URT 1 REMARK REVDAT 1 30-OCT-24 8URT 0 JRNL AUTH J.R.ROBERTS,Y.HORIBATA,F.KWARCINSKI,V.LAM,A.M.RACZKOWSKI, JRNL AUTH 2 A.HUBBARD,H.SUGIMOTO,G.G.TALL,M.D.OHI,S.MAEDA JRNL TITL STRUCTURAL BASIS FOR CATALYSIS AND SELECTIVITY OF JRNL TITL 2 PHOSPHOLIPID SYNTHESIS BY EUKARYOTIC JRNL TITL 3 CHOLINE-PHOSPHOTRANSFERASE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, SERIALEM, CRYOSPARC, PHENIX, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : CROSS-CORRELATION COEFFICIENT REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : INITIAL MODEL FITTING WAS DONE USING A MODEL REMARK 3 SUPERPOSITION FUNCTION INTO A 3D VOLUME IN CHIMERA AND THEN REMARK 3 PHENIX.REAL_SPACE_REFINE WAS USED FOR FLEXIBLE FITTING. REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.100 REMARK 3 NUMBER OF PARTICLES : 371370 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8URT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1000275419. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : YCPT1; YCPT1; NANOBODY25 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 2990 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2400.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 81000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 389 REMARK 465 PRO A 390 REMARK 465 LYS A 391 REMARK 465 GLU A 392 REMARK 465 ILE A 393 REMARK 465 HIS B 389 REMARK 465 PRO B 390 REMARK 465 LYS B 391 REMARK 465 GLU B 392 REMARK 465 ILE B 393 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO B 78 OG1 THR B 81 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 5 72.47 56.75 REMARK 500 VAL A 30 -60.64 -107.69 REMARK 500 PRO A 176 42.51 -83.75 REMARK 500 GLN A 209 -141.86 65.10 REMARK 500 LYS A 256 -8.31 71.79 REMARK 500 ASP A 343 35.03 -98.98 REMARK 500 PHE B 3 -5.81 72.41 REMARK 500 VAL B 30 -60.05 -103.51 REMARK 500 PHE B 211 -148.78 52.63 REMARK 500 SER B 251 29.82 -140.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1001 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 96 OD1 REMARK 620 2 ASP A 117 OD2 92.6 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 96 OD1 REMARK 620 2 ASP A 96 OD2 51.3 REMARK 620 3 ASP A 121 OD1 162.5 111.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 402 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 96 O REMARK 620 2 ASP B 96 OD1 61.6 REMARK 620 3 ASP B 99 OD1 62.4 109.4 REMARK 620 4 ASP B 99 OD2 96.1 98.6 50.3 REMARK 620 5 ASP B 117 OD2 142.1 80.9 144.0 94.8 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8UL9 RELATED DB: PDB REMARK 900 RELATED ID: 8URP RELATED DB: PDB REMARK 900 RELATED ID: EMD-42500 RELATED DB: EMDB REMARK 900 MEMBRANE PROTEIN ENZYME WITH A SPECIFIC INHIBITOR DBREF 8URT A 2 393 UNP P17898 CPT1_YEAST 2 393 DBREF 8URT B 2 393 UNP P17898 CPT1_YEAST 2 393 SEQADV 8URT ACE A 1 UNP P17898 ACETYLATION SEQADV 8URT ACE B 1 UNP P17898 ACETYLATION SEQRES 1 A 393 ACE GLY PHE PHE ILE PRO GLN SER SER LEU GLY ASN LEU SEQRES 2 A 393 LYS LEU TYR LYS TYR GLN SER ASP ASP ARG SER PHE LEU SEQRES 3 A 393 SER ASN HIS VAL LEU ARG PRO PHE TRP ARG LYS PHE ALA SEQRES 4 A 393 THR ILE PHE PRO LEU TRP MET ALA PRO ASN LEU VAL THR SEQRES 5 A 393 LEU LEU GLY PHE CYS PHE ILE ILE PHE ASN VAL LEU THR SEQRES 6 A 393 THR LEU TYR TYR ASP PRO TYR PHE ASP GLN GLU SER PRO SEQRES 7 A 393 ARG TRP THR TYR PHE SER TYR ALA ILE GLY LEU PHE LEU SEQRES 8 A 393 TYR GLN THR PHE ASP ALA CYS ASP GLY MET HIS ALA ARG SEQRES 9 A 393 ARG THR GLY GLN GLN GLY PRO LEU GLY GLU LEU PHE ASP SEQRES 10 A 393 HIS CYS ILE ASP SER ILE ASN THR THR LEU SER MET ILE SEQRES 11 A 393 PRO VAL CYS SER MET THR GLY MET GLY TYR THR TYR MET SEQRES 12 A 393 THR ILE PHE SER GLN PHE ALA ILE LEU CYS SER PHE TYR SEQRES 13 A 393 LEU SER THR TRP GLU GLU TYR HIS THR HIS LYS LEU TYR SEQRES 14 A 393 LEU ALA GLU PHE CYS GLY PRO VAL GLU GLY ILE ILE VAL SEQRES 15 A 393 LEU CYS ILE SER PHE ILE ALA VAL GLY ILE TYR GLY PRO SEQRES 16 A 393 GLN THR ILE TRP HIS THR LYS VAL ALA GLN PHE SER TRP SEQRES 17 A 393 GLN ASP PHE VAL PHE ASP VAL GLU THR VAL HIS LEU MET SEQRES 18 A 393 TYR ALA PHE CYS THR GLY ALA LEU ILE PHE ASN ILE VAL SEQRES 19 A 393 THR ALA HIS THR ASN VAL VAL ARG TYR TYR GLU SER GLN SEQRES 20 A 393 SER THR LYS SER ALA THR PRO SER LYS THR ALA GLU ASN SEQRES 21 A 393 ILE SER LYS ALA VAL ASN GLY LEU LEU PRO PHE PHE ALA SEQRES 22 A 393 TYR PHE SER SER ILE PHE THR LEU VAL LEU ILE GLN PRO SEQRES 23 A 393 SER PHE ILE SER LEU ALA LEU ILE LEU SER ILE GLY PHE SEQRES 24 A 393 SER VAL ALA PHE VAL VAL GLY ARG MET ILE ILE ALA HIS SEQRES 25 A 393 LEU THR MET GLN PRO PHE PRO MET VAL ASN PHE PRO PHE SEQRES 26 A 393 LEU ILE PRO THR ILE GLN LEU VAL LEU TYR ALA PHE MET SEQRES 27 A 393 VAL TYR VAL LEU ASP TYR GLN LYS GLY SER ILE VAL SER SEQRES 28 A 393 ALA LEU VAL TRP MET GLY LEU GLY LEU THR LEU ALA ILE SEQRES 29 A 393 HIS GLY MET PHE ILE ASN ASP ILE ILE TYR ASP ILE THR SEQRES 30 A 393 THR PHE LEU ASP ILE TYR ALA LEU SER ILE LYS HIS PRO SEQRES 31 A 393 LYS GLU ILE SEQRES 1 B 393 ACE GLY PHE PHE ILE PRO GLN SER SER LEU GLY ASN LEU SEQRES 2 B 393 LYS LEU TYR LYS TYR GLN SER ASP ASP ARG SER PHE LEU SEQRES 3 B 393 SER ASN HIS VAL LEU ARG PRO PHE TRP ARG LYS PHE ALA SEQRES 4 B 393 THR ILE PHE PRO LEU TRP MET ALA PRO ASN LEU VAL THR SEQRES 5 B 393 LEU LEU GLY PHE CYS PHE ILE ILE PHE ASN VAL LEU THR SEQRES 6 B 393 THR LEU TYR TYR ASP PRO TYR PHE ASP GLN GLU SER PRO SEQRES 7 B 393 ARG TRP THR TYR PHE SER TYR ALA ILE GLY LEU PHE LEU SEQRES 8 B 393 TYR GLN THR PHE ASP ALA CYS ASP GLY MET HIS ALA ARG SEQRES 9 B 393 ARG THR GLY GLN GLN GLY PRO LEU GLY GLU LEU PHE ASP SEQRES 10 B 393 HIS CYS ILE ASP SER ILE ASN THR THR LEU SER MET ILE SEQRES 11 B 393 PRO VAL CYS SER MET THR GLY MET GLY TYR THR TYR MET SEQRES 12 B 393 THR ILE PHE SER GLN PHE ALA ILE LEU CYS SER PHE TYR SEQRES 13 B 393 LEU SER THR TRP GLU GLU TYR HIS THR HIS LYS LEU TYR SEQRES 14 B 393 LEU ALA GLU PHE CYS GLY PRO VAL GLU GLY ILE ILE VAL SEQRES 15 B 393 LEU CYS ILE SER PHE ILE ALA VAL GLY ILE TYR GLY PRO SEQRES 16 B 393 GLN THR ILE TRP HIS THR LYS VAL ALA GLN PHE SER TRP SEQRES 17 B 393 GLN ASP PHE VAL PHE ASP VAL GLU THR VAL HIS LEU MET SEQRES 18 B 393 TYR ALA PHE CYS THR GLY ALA LEU ILE PHE ASN ILE VAL SEQRES 19 B 393 THR ALA HIS THR ASN VAL VAL ARG TYR TYR GLU SER GLN SEQRES 20 B 393 SER THR LYS SER ALA THR PRO SER LYS THR ALA GLU ASN SEQRES 21 B 393 ILE SER LYS ALA VAL ASN GLY LEU LEU PRO PHE PHE ALA SEQRES 22 B 393 TYR PHE SER SER ILE PHE THR LEU VAL LEU ILE GLN PRO SEQRES 23 B 393 SER PHE ILE SER LEU ALA LEU ILE LEU SER ILE GLY PHE SEQRES 24 B 393 SER VAL ALA PHE VAL VAL GLY ARG MET ILE ILE ALA HIS SEQRES 25 B 393 LEU THR MET GLN PRO PHE PRO MET VAL ASN PHE PRO PHE SEQRES 26 B 393 LEU ILE PRO THR ILE GLN LEU VAL LEU TYR ALA PHE MET SEQRES 27 B 393 VAL TYR VAL LEU ASP TYR GLN LYS GLY SER ILE VAL SER SEQRES 28 B 393 ALA LEU VAL TRP MET GLY LEU GLY LEU THR LEU ALA ILE SEQRES 29 B 393 HIS GLY MET PHE ILE ASN ASP ILE ILE TYR ASP ILE THR SEQRES 30 B 393 THR PHE LEU ASP ILE TYR ALA LEU SER ILE LYS HIS PRO SEQRES 31 B 393 LYS GLU ILE HET ACE A 1 3 HET ACE B 1 3 HET MG A1001 1 HET MG A1002 1 HET PCW A1003 54 HET PCW A1004 54 HET CTI A1005 26 HET PCW A1006 54 HET PCW A1007 54 HET PCW B 401 54 HET MG B 402 1 HET MG B 403 1 HET PCW B 404 54 HET CTI B 405 26 HETNAM ACE ACETYL GROUP HETNAM MG MAGNESIUM ION HETNAM PCW 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE HETNAM CTI 1,2-DIMETHOXY-12-METHYL[1,3]BENZODIOXOLO[5,6- HETNAM 2 CTI C]PHENANTHRIDIN-12-IUM HETSYN PCW (Z,Z)-4-HYDROXY-N,N,N-TRIMETHYL-10-OXO-7-[(1-OXO-9- HETSYN 2 PCW OCTADECENYL)OXY]-3,5,9-TRIOXA-4-PHOSPHAHEPTACOS-18-EN- HETSYN 3 PCW 1-AMINIUM-4-OXIDE HETSYN CTI CHELERYTHRINE FORMUL 1 ACE 2(C2 H4 O) FORMUL 3 MG 4(MG 2+) FORMUL 5 PCW 6(C44 H85 N O8 P 1+) FORMUL 7 CTI 2(C21 H18 N O4 1+) FORMUL 15 HOH *2(H2 O) HELIX 1 AA1 PRO A 6 LYS A 14 5 9 HELIX 2 AA2 SER A 24 VAL A 30 1 7 HELIX 3 AA3 VAL A 30 ALA A 39 1 10 HELIX 4 AA4 ALA A 47 ASP A 70 1 24 HELIX 5 AA5 ARG A 79 THR A 106 1 28 HELIX 6 AA6 GLY A 110 GLY A 137 1 28 HELIX 7 AA7 THR A 141 THR A 165 1 25 HELIX 8 AA8 VAL A 177 TYR A 193 1 17 HELIX 9 AA9 GLY A 194 HIS A 200 1 7 HELIX 10 AB1 THR A 217 LYS A 250 1 34 HELIX 11 AB2 LYS A 256 GLY A 267 1 12 HELIX 12 AB3 LEU A 268 GLN A 285 1 18 HELIX 13 AB4 PRO A 286 ILE A 289 5 4 HELIX 14 AB5 SER A 290 THR A 314 1 25 HELIX 15 AB6 ASN A 322 PHE A 325 5 4 HELIX 16 AB7 LEU A 326 VAL A 341 1 16 HELIX 17 AB8 ILE A 349 ASP A 381 1 33 HELIX 18 AB9 PRO B 6 LEU B 15 5 10 HELIX 19 AC1 SER B 24 VAL B 30 1 7 HELIX 20 AC2 VAL B 30 ALA B 39 1 10 HELIX 21 AC3 THR B 40 PHE B 42 5 3 HELIX 22 AC4 LEU B 50 ASP B 70 1 21 HELIX 23 AC5 PRO B 78 GLY B 107 1 30 HELIX 24 AC6 GLY B 110 GLY B 137 1 28 HELIX 25 AC7 THR B 141 HIS B 166 1 26 HELIX 26 AC8 GLY B 175 TYR B 193 1 19 HELIX 27 AC9 GLY B 194 TRP B 199 1 6 HELIX 28 AD1 THR B 217 ALA B 252 1 36 HELIX 29 AD2 THR B 253 ASN B 266 1 14 HELIX 30 AD3 LEU B 268 GLN B 285 1 18 HELIX 31 AD4 PRO B 286 ILE B 289 5 4 HELIX 32 AD5 SER B 290 MET B 315 1 26 HELIX 33 AD6 ASN B 322 PHE B 325 5 4 HELIX 34 AD7 LEU B 326 VAL B 341 1 16 HELIX 35 AD8 GLN B 345 ASP B 381 1 37 SHEET 1 AA1 2 SER A 20 ASP A 22 0 SHEET 2 AA1 2 LEU A 168 LEU A 170 1 O LEU A 168 N ASP A 21 SHEET 1 AA2 2 LYS A 202 ALA A 204 0 SHEET 2 AA2 2 VAL A 215 GLU A 216 -1 O VAL A 215 N VAL A 203 SHEET 1 AA3 2 LYS B 202 GLN B 205 0 SHEET 2 AA3 2 ASP B 214 GLU B 216 -1 O VAL B 215 N VAL B 203 LINK C ACE A 1 N GLY A 2 1555 1555 1.33 LINK C ACE B 1 N GLY B 2 1555 1555 1.33 LINK OD1 ASP A 96 MG MG A1001 1555 1555 2.47 LINK OD1 ASP A 96 MG MG A1002 1555 1555 2.77 LINK OD2 ASP A 96 MG MG A1002 1555 1555 2.11 LINK OD2 ASP A 117 MG MG A1001 1555 1555 2.05 LINK OD1 ASP A 121 MG MG A1002 1555 1555 2.15 LINK OH TYR B 92 MG MG B 403 1555 1555 2.00 LINK O ASP B 96 MG MG B 402 1555 1555 2.84 LINK OD1 ASP B 96 MG MG B 402 1555 1555 2.86 LINK OD1 ASP B 99 MG MG B 402 1555 1555 2.37 LINK OD2 ASP B 99 MG MG B 402 1555 1555 2.73 LINK OD2 ASP B 117 MG MG B 402 1555 1555 2.05 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 HETATM 1 C ACE A 1 139.491 137.061 126.052 1.00 91.06 C HETATM 2 O ACE A 1 138.484 137.039 126.686 1.00 98.63 O HETATM 3 CH3 ACE A 1 139.542 136.482 124.655 1.00 82.05 C